Skip to Main Content

The floodgates for direct-to-consumer genetic tests are swinging wide open.

The Food and Drug Administration plans on loosening many of the regulations surrounding genetic health risk tests, or GHRs, according to a statement Monday from Commissioner Scott Gottlieb. It’s a change of course for the agency, which in 2013 put a freeze on direct-to-consumer marketing of genetic tests for health conditions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!